Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malpractice | 61 | 2009 | 569 | 4.390 |
Why?
|
Medical Errors | 40 | 2007 | 1296 | 3.660 |
Why?
|
Iatrogenic Disease | 35 | 2010 | 545 | 3.290 |
Why?
|
Liability, Legal | 28 | 2010 | 213 | 2.920 |
Why?
|
Pharmacies | 13 | 2017 | 150 | 2.350 |
Why?
|
Drug Industry | 14 | 2022 | 744 | 2.290 |
Why?
|
Medication Adherence | 37 | 2020 | 2055 | 2.090 |
Why?
|
Drug Costs | 13 | 2023 | 1104 | 2.050 |
Why?
|
Pharmaceutical Services | 7 | 2016 | 140 | 1.790 |
Why?
|
Ethics, Medical | 26 | 2007 | 791 | 1.750 |
Why?
|
Managed Care Programs | 19 | 2008 | 949 | 1.660 |
Why?
|
Safety Management | 11 | 2010 | 782 | 1.540 |
Why?
|
Insurance, Liability | 16 | 2007 | 102 | 1.530 |
Why?
|
Quality of Health Care | 35 | 2014 | 4369 | 1.400 |
Why?
|
Government Regulation | 12 | 2010 | 522 | 1.360 |
Why?
|
Commerce | 7 | 2017 | 591 | 1.280 |
Why?
|
Social Control, Formal | 4 | 2014 | 110 | 1.260 |
Why?
|
Prescription Drugs | 12 | 2017 | 595 | 1.220 |
Why?
|
Drugs, Generic | 9 | 2016 | 422 | 1.200 |
Why?
|
Compensation and Redress | 11 | 2007 | 71 | 1.180 |
Why?
|
Insurance, Health | 20 | 2017 | 2493 | 1.170 |
Why?
|
Health Care Reform | 11 | 2011 | 1261 | 1.160 |
Why?
|
Marketing | 3 | 2022 | 208 | 1.100 |
Why?
|
United States | 153 | 2022 | 69693 | 1.070 |
Why?
|
Medical Audit | 14 | 2010 | 467 | 1.060 |
Why?
|
Cost Control | 11 | 2023 | 624 | 1.040 |
Why?
|
Quality Assurance, Health Care | 19 | 2009 | 2211 | 1.030 |
Why?
|
Capitation Fee | 7 | 2005 | 116 | 0.940 |
Why?
|
Total Quality Management | 10 | 2007 | 274 | 0.930 |
Why?
|
Legislation, Drug | 2 | 2022 | 206 | 0.830 |
Why?
|
Insurance, Pharmaceutical Services | 7 | 2016 | 336 | 0.820 |
Why?
|
Risk Management | 13 | 2007 | 571 | 0.770 |
Why?
|
Defensive Medicine | 5 | 2010 | 48 | 0.740 |
Why?
|
Conflict of Interest | 7 | 2017 | 542 | 0.720 |
Why?
|
Social Responsibility | 11 | 2007 | 389 | 0.720 |
Why?
|
Physician's Role | 8 | 2010 | 942 | 0.710 |
Why?
|
Internal Medicine | 8 | 2005 | 1009 | 0.700 |
Why?
|
Insurance Carriers | 6 | 2022 | 156 | 0.700 |
Why?
|
Hospitals | 17 | 2003 | 3937 | 0.670 |
Why?
|
Medicare Part C | 2 | 2021 | 296 | 0.640 |
Why?
|
Jurisprudence | 7 | 2007 | 109 | 0.640 |
Why?
|
Life Support Care | 6 | 2004 | 228 | 0.640 |
Why?
|
Patient Satisfaction | 18 | 2015 | 3391 | 0.640 |
Why?
|
Drug Prescriptions | 8 | 2017 | 1636 | 0.630 |
Why?
|
Hepatitis C, Chronic | 3 | 2015 | 1027 | 0.620 |
Why?
|
Physicians | 21 | 2017 | 4554 | 0.620 |
Why?
|
Health Services Accessibility | 17 | 2019 | 5133 | 0.620 |
Why?
|
Hospitals, Teaching | 19 | 2003 | 1179 | 0.610 |
Why?
|
Gift Giving | 3 | 2007 | 80 | 0.600 |
Why?
|
Academic Medical Centers | 7 | 2017 | 2749 | 0.600 |
Why?
|
Practice Guidelines as Topic | 12 | 2015 | 7276 | 0.580 |
Why?
|
Utah | 12 | 2007 | 126 | 0.570 |
Why?
|
Humans | 289 | 2023 | 742088 | 0.560 |
Why?
|
Colorado | 12 | 2007 | 162 | 0.560 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 15 | 2020 | 3239 | 0.550 |
Why?
|
Physicians, Family | 5 | 2007 | 345 | 0.550 |
Why?
|
Fraud | 3 | 2005 | 67 | 0.540 |
Why?
|
Hospital Records | 6 | 2010 | 95 | 0.540 |
Why?
|
Antiviral Agents | 5 | 2015 | 2978 | 0.530 |
Why?
|
State Health Plans | 3 | 2009 | 216 | 0.530 |
Why?
|
Health Expenditures | 6 | 2019 | 2346 | 0.510 |
Why?
|
Cardiovascular Agents | 9 | 2017 | 848 | 0.510 |
Why?
|
Health Services Misuse | 5 | 2014 | 243 | 0.510 |
Why?
|
Proprotein Convertases | 1 | 2015 | 95 | 0.500 |
Why?
|
Health Benefit Plans, Employee | 3 | 2013 | 332 | 0.500 |
Why?
|
Hospital Administration | 4 | 2003 | 353 | 0.490 |
Why?
|
Delivery of Health Care | 11 | 2016 | 5304 | 0.490 |
Why?
|
Prescription Fees | 5 | 2015 | 146 | 0.480 |
Why?
|
Cost Sharing | 4 | 2023 | 407 | 0.480 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.480 |
Why?
|
Insurance Coverage | 12 | 2015 | 1895 | 0.480 |
Why?
|
Ambulatory Care | 7 | 2007 | 2706 | 0.480 |
Why?
|
Hospitals, Voluntary | 2 | 2007 | 40 | 0.470 |
Why?
|
Physician-Patient Relations | 16 | 2016 | 3215 | 0.470 |
Why?
|
Biological Factors | 1 | 2015 | 164 | 0.470 |
Why?
|
Insurance Claim Review | 13 | 2016 | 720 | 0.460 |
Why?
|
Organizational Policy | 6 | 2017 | 427 | 0.460 |
Why?
|
Fee Schedules | 1 | 2013 | 86 | 0.460 |
Why?
|
Medicare | 13 | 2022 | 6532 | 0.460 |
Why?
|
Specialty Boards | 2 | 2006 | 227 | 0.450 |
Why?
|
Medication Therapy Management | 2 | 2015 | 127 | 0.450 |
Why?
|
Dissent and Disputes | 3 | 2003 | 138 | 0.450 |
Why?
|
Fees, Medical | 2 | 2005 | 117 | 0.440 |
Why?
|
Health Services Research | 16 | 2014 | 1834 | 0.440 |
Why?
|
Hepatitis C | 1 | 2023 | 1582 | 0.440 |
Why?
|
Hospitals, Community | 2 | 2005 | 348 | 0.430 |
Why?
|
Public Policy | 7 | 2014 | 572 | 0.430 |
Why?
|
Truth Disclosure | 4 | 2005 | 435 | 0.430 |
Why?
|
Certification | 2 | 2006 | 423 | 0.420 |
Why?
|
Reminder Systems | 4 | 2018 | 370 | 0.420 |
Why?
|
Diagnostic Errors | 7 | 2010 | 1255 | 0.420 |
Why?
|
Reimbursement, Incentive | 5 | 2020 | 540 | 0.420 |
Why?
|
Ethics | 5 | 1999 | 93 | 0.420 |
Why?
|
Interinstitutional Relations | 4 | 2006 | 240 | 0.410 |
Why?
|
Health Policy | 10 | 2009 | 2657 | 0.410 |
Why?
|
Chronic Disease | 9 | 2017 | 9144 | 0.400 |
Why?
|
Hospitals, Urban | 9 | 2001 | 499 | 0.400 |
Why?
|
New York | 20 | 2017 | 886 | 0.400 |
Why?
|
Ambulatory Care Facilities | 3 | 2014 | 932 | 0.390 |
Why?
|
Cost Savings | 3 | 2016 | 925 | 0.390 |
Why?
|
Postal Service | 1 | 2011 | 96 | 0.390 |
Why?
|
Research Subjects | 5 | 2003 | 238 | 0.380 |
Why?
|
Inappropriate Prescribing | 1 | 2013 | 202 | 0.380 |
Why?
|
Boston | 29 | 2005 | 9305 | 0.380 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 604 | 0.380 |
Why?
|
Primary Health Care | 10 | 2013 | 4551 | 0.370 |
Why?
|
Drug Approval | 2 | 2015 | 740 | 0.370 |
Why?
|
Hyperlipidemias | 1 | 2015 | 786 | 0.370 |
Why?
|
Legislation, Medical | 4 | 2007 | 100 | 0.370 |
Why?
|
Patient Care | 3 | 2005 | 639 | 0.370 |
Why?
|
Interprofessional Relations | 6 | 2017 | 1008 | 0.370 |
Why?
|
Health Services | 3 | 2013 | 758 | 0.360 |
Why?
|
Marketing of Health Services | 3 | 2007 | 153 | 0.360 |
Why?
|
Costs and Cost Analysis | 11 | 2015 | 1679 | 0.360 |
Why?
|
Employee Retirement Income Security Act | 3 | 2005 | 9 | 0.360 |
Why?
|
Insurance, Health, Reimbursement | 4 | 2010 | 395 | 0.360 |
Why?
|
Information Services | 3 | 2000 | 244 | 0.360 |
Why?
|
Health Care Sector | 3 | 2010 | 194 | 0.360 |
Why?
|
Hospital-Physician Joint Ventures | 2 | 1999 | 30 | 0.350 |
Why?
|
Women's Health Services | 2 | 2000 | 93 | 0.350 |
Why?
|
Medical Records | 10 | 2005 | 1413 | 0.350 |
Why?
|
Emergency Service, Hospital | 14 | 2015 | 7645 | 0.350 |
Why?
|
Middle Aged | 108 | 2021 | 213127 | 0.350 |
Why?
|
Cost-Benefit Analysis | 15 | 2016 | 5385 | 0.350 |
Why?
|
Drug Utilization | 8 | 2016 | 1181 | 0.350 |
Why?
|
Patient-Centered Care | 3 | 2014 | 1436 | 0.340 |
Why?
|
Medical Staff, Hospital | 6 | 2006 | 603 | 0.340 |
Why?
|
Guideline Adherence | 8 | 2014 | 2266 | 0.340 |
Why?
|
Female | 134 | 2021 | 379592 | 0.330 |
Why?
|
Disclosure | 6 | 2007 | 736 | 0.330 |
Why?
|
Ownership | 3 | 2000 | 331 | 0.330 |
Why?
|
Case Management | 2 | 2014 | 286 | 0.330 |
Why?
|
Patient Compliance | 5 | 2017 | 2680 | 0.330 |
Why?
|
Insurance Claim Reporting | 5 | 2017 | 163 | 0.320 |
Why?
|
Physician Incentive Plans | 3 | 2009 | 161 | 0.320 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2010 | 236 | 0.320 |
Why?
|
Propensity Score | 9 | 2019 | 1771 | 0.320 |
Why?
|
Decision Making | 10 | 2004 | 3869 | 0.310 |
Why?
|
Aged | 82 | 2022 | 162944 | 0.310 |
Why?
|
Public Health | 7 | 2017 | 2594 | 0.310 |
Why?
|
Multiple Sclerosis | 1 | 2022 | 3076 | 0.310 |
Why?
|
Male | 115 | 2021 | 349538 | 0.310 |
Why?
|
Hypercholesterolemia | 1 | 2014 | 1149 | 0.310 |
Why?
|
Treatment Refusal | 2 | 2004 | 416 | 0.300 |
Why?
|
Job Satisfaction | 4 | 2005 | 535 | 0.300 |
Why?
|
Radiation Oncology | 1 | 2013 | 554 | 0.300 |
Why?
|
Tax Exemption | 1 | 2007 | 15 | 0.300 |
Why?
|
Thiazolidinediones | 4 | 2014 | 476 | 0.300 |
Why?
|
Remote Consultation | 1 | 2010 | 238 | 0.300 |
Why?
|
Family Practice | 2 | 2000 | 516 | 0.300 |
Why?
|
Cholesterol, LDL | 2 | 2020 | 2354 | 0.300 |
Why?
|
Cystitis, Interstitial | 2 | 1998 | 61 | 0.290 |
Why?
|
Benchmarking | 4 | 2000 | 1038 | 0.290 |
Why?
|
Drug Labeling | 1 | 2009 | 231 | 0.290 |
Why?
|
History, 20th Century | 9 | 2009 | 2739 | 0.290 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2004 | 979 | 0.290 |
Why?
|
Self Care | 3 | 1998 | 786 | 0.290 |
Why?
|
Continuity of Patient Care | 6 | 2016 | 1048 | 0.290 |
Why?
|
Health Care Costs | 9 | 2017 | 3203 | 0.280 |
Why?
|
Medically Uninsured | 4 | 1998 | 852 | 0.280 |
Why?
|
Intensive Care Units | 3 | 2005 | 3679 | 0.280 |
Why?
|
Cardiovascular Diseases | 12 | 2020 | 15108 | 0.270 |
Why?
|
Rate Setting and Review | 2 | 2004 | 41 | 0.270 |
Why?
|
Adult | 88 | 2021 | 213712 | 0.270 |
Why?
|
Food Industry | 1 | 2006 | 68 | 0.270 |
Why?
|
Efficiency, Organizational | 3 | 2007 | 695 | 0.260 |
Why?
|
Program Evaluation | 5 | 2016 | 2485 | 0.260 |
Why?
|
Organizational Affiliation | 1 | 2005 | 32 | 0.260 |
Why?
|
Patient Freedom of Choice Laws | 1 | 2005 | 5 | 0.260 |
Why?
|
Wounds and Injuries | 9 | 2007 | 2400 | 0.260 |
Why?
|
Social Justice | 4 | 2004 | 455 | 0.250 |
Why?
|
United States Food and Drug Administration | 6 | 2015 | 1581 | 0.250 |
Why?
|
Hospitals, Special | 1 | 2005 | 101 | 0.250 |
Why?
|
Social Change | 4 | 1999 | 153 | 0.250 |
Why?
|
Medication Reconciliation | 2 | 2016 | 151 | 0.250 |
Why?
|
Politics | 4 | 2005 | 790 | 0.240 |
Why?
|
Current Procedural Terminology | 1 | 2005 | 92 | 0.240 |
Why?
|
Confidentiality | 6 | 2000 | 609 | 0.240 |
Why?
|
Quality Indicators, Health Care | 6 | 2014 | 1831 | 0.240 |
Why?
|
Length of Stay | 6 | 2005 | 6294 | 0.240 |
Why?
|
Appetite Depressants | 2 | 2013 | 110 | 0.240 |
Why?
|
United States Office of Research Integrity | 1 | 2003 | 9 | 0.240 |
Why?
|
Patient Advocacy | 7 | 2010 | 353 | 0.240 |
Why?
|
Logistic Models | 21 | 2017 | 13403 | 0.240 |
Why?
|
Health Promotion | 5 | 2012 | 2194 | 0.240 |
Why?
|
Safety | 2 | 2006 | 1185 | 0.240 |
Why?
|
Human Rights | 3 | 1998 | 302 | 0.240 |
Why?
|
National Practitioner Data Bank | 2 | 2003 | 13 | 0.230 |
Why?
|
Multivariate Analysis | 21 | 2016 | 12242 | 0.230 |
Why?
|
Economics | 3 | 2007 | 146 | 0.230 |
Why?
|
Specialties, Surgical | 2 | 2005 | 389 | 0.230 |
Why?
|
Supreme Court Decisions | 1 | 2005 | 128 | 0.230 |
Why?
|
Withholding Treatment | 7 | 2003 | 598 | 0.230 |
Why?
|
Hospitals, Proprietary | 2 | 2000 | 39 | 0.230 |
Why?
|
State Government | 4 | 2010 | 369 | 0.230 |
Why?
|
Massachusetts | 14 | 2017 | 8662 | 0.220 |
Why?
|
Reimbursement Mechanisms | 3 | 2014 | 670 | 0.220 |
Why?
|
Insurance Benefits | 1 | 2005 | 183 | 0.220 |
Why?
|
Minority Groups | 3 | 2008 | 1215 | 0.220 |
Why?
|
Patients | 3 | 2004 | 892 | 0.220 |
Why?
|
Scientific Misconduct | 1 | 2003 | 71 | 0.220 |
Why?
|
Ethics Committees, Clinical | 5 | 1992 | 56 | 0.220 |
Why?
|
Facility Regulation and Control | 2 | 1999 | 24 | 0.220 |
Why?
|
Human Experimentation | 2 | 1999 | 127 | 0.220 |
Why?
|
Socioeconomic Factors | 19 | 2018 | 7770 | 0.220 |
Why?
|
Professional-Family Relations | 2 | 2004 | 481 | 0.220 |
Why?
|
Hypoglycemic Agents | 5 | 2017 | 2866 | 0.210 |
Why?
|
Physician Impairment | 1 | 2003 | 73 | 0.210 |
Why?
|
Negotiating | 2 | 2003 | 133 | 0.210 |
Why?
|
Euthanasia, Passive | 3 | 1993 | 66 | 0.210 |
Why?
|
Living Donors | 1 | 2007 | 618 | 0.210 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 5 | 2005 | 93 | 0.210 |
Why?
|
Collective Bargaining | 1 | 2001 | 3 | 0.210 |
Why?
|
Antitrust Laws | 1 | 2001 | 7 | 0.210 |
Why?
|
Communication | 5 | 2016 | 3728 | 0.210 |
Why?
|
Freedom | 3 | 1998 | 69 | 0.210 |
Why?
|
Resource Allocation | 8 | 2002 | 341 | 0.210 |
Why?
|
Medical Records Systems, Computerized | 3 | 1999 | 1204 | 0.210 |
Why?
|
Guidelines as Topic | 7 | 2012 | 1402 | 0.210 |
Why?
|
Healthcare Disparities | 4 | 2014 | 3151 | 0.200 |
Why?
|
Personal Autonomy | 5 | 1998 | 297 | 0.200 |
Why?
|
Moral Obligations | 5 | 1999 | 96 | 0.200 |
Why?
|
Homeless Persons | 1 | 2001 | 8 | 0.200 |
Why?
|
Mammography | 3 | 2004 | 2474 | 0.200 |
Why?
|
Reward | 2 | 2020 | 940 | 0.200 |
Why?
|
Private Practice | 1 | 2002 | 154 | 0.200 |
Why?
|
Patient Admission | 3 | 2002 | 1380 | 0.200 |
Why?
|
Work Schedule Tolerance | 3 | 2003 | 565 | 0.200 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2003 | 501 | 0.190 |
Why?
|
Obstetrics | 3 | 2005 | 657 | 0.190 |
Why?
|
Birth Injuries | 2 | 2000 | 148 | 0.190 |
Why?
|
Health Occupations | 1 | 2002 | 223 | 0.190 |
Why?
|
Analgesics, Opioid | 2 | 2016 | 3667 | 0.190 |
Why?
|
Medical History Taking | 1 | 2005 | 783 | 0.190 |
Why?
|
Thiophenes | 3 | 2014 | 590 | 0.190 |
Why?
|
Breast Diseases | 1 | 2004 | 443 | 0.190 |
Why?
|
Adolescent | 40 | 2017 | 85649 | 0.190 |
Why?
|
Data Collection | 12 | 2003 | 3339 | 0.190 |
Why?
|
Infant, Newborn | 20 | 2014 | 25575 | 0.190 |
Why?
|
Anticholesteremic Agents | 4 | 2020 | 979 | 0.190 |
Why?
|
Lawyers | 3 | 2006 | 38 | 0.180 |
Why?
|
Trauma, Nervous System | 1 | 2000 | 36 | 0.180 |
Why?
|
Counseling | 2 | 2005 | 1521 | 0.180 |
Why?
|
Internationality | 4 | 2006 | 1002 | 0.180 |
Why?
|
Risk Sharing, Financial | 2 | 1999 | 47 | 0.180 |
Why?
|
Catastrophic Illness | 1 | 2000 | 57 | 0.180 |
Why?
|
Accounts Payable and Receivable | 1 | 1999 | 12 | 0.180 |
Why?
|
Disease Management | 2 | 2012 | 2450 | 0.180 |
Why?
|
Medicare Part B | 1 | 2021 | 108 | 0.180 |
Why?
|
Medicaid | 5 | 2004 | 2716 | 0.180 |
Why?
|
Health Maintenance Organizations | 3 | 2000 | 642 | 0.180 |
Why?
|
Helsinki Declaration | 1 | 1999 | 6 | 0.180 |
Why?
|
Medical Staff Privileges | 1 | 1999 | 14 | 0.180 |
Why?
|
Specialization | 7 | 2008 | 777 | 0.180 |
Why?
|
Urban Health Services | 1 | 2001 | 179 | 0.180 |
Why?
|
Clinical Medicine | 2 | 1991 | 147 | 0.180 |
Why?
|
Critical Pathways | 2 | 2003 | 475 | 0.180 |
Why?
|
Health Care Surveys | 8 | 2007 | 2451 | 0.180 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 5 | 2013 | 1517 | 0.180 |
Why?
|
Science | 2 | 2001 | 241 | 0.170 |
Why?
|
Surgical Procedures, Operative | 2 | 2003 | 1873 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 5 | 2021 | 3014 | 0.170 |
Why?
|
Pharmacists | 3 | 2016 | 240 | 0.170 |
Why?
|
Retrospective Studies | 27 | 2021 | 77098 | 0.170 |
Why?
|
Attitude to Health | 5 | 2007 | 2051 | 0.170 |
Why?
|
Internship and Residency | 7 | 2005 | 5774 | 0.170 |
Why?
|
Insurance, Hospitalization | 1 | 1998 | 30 | 0.170 |
Why?
|
Patient Discharge | 8 | 2016 | 3300 | 0.170 |
Why?
|
Peer Review, Health Care | 1 | 1999 | 75 | 0.170 |
Why?
|
Myocardial Infarction | 8 | 2015 | 11690 | 0.170 |
Why?
|
Hospitalization | 6 | 2007 | 10232 | 0.170 |
Why?
|
Delivery of Health Care, Integrated | 3 | 2005 | 941 | 0.170 |
Why?
|
Patient Selection | 5 | 2008 | 4214 | 0.170 |
Why?
|
Consumer Advocacy | 3 | 2006 | 81 | 0.170 |
Why?
|
Tissue and Organ Procurement | 1 | 2007 | 890 | 0.160 |
Why?
|
Influenza Vaccines | 2 | 2005 | 733 | 0.160 |
Why?
|
Evaluation Studies as Topic | 8 | 2008 | 1676 | 0.160 |
Why?
|
Cross-Sectional Studies | 21 | 2021 | 24913 | 0.160 |
Why?
|
Research Personnel | 1 | 2003 | 573 | 0.160 |
Why?
|
Acquired Immunodeficiency Syndrome | 5 | 1997 | 2231 | 0.160 |
Why?
|
Health Status | 4 | 2015 | 4030 | 0.160 |
Why?
|
Goals | 1 | 2004 | 705 | 0.160 |
Why?
|
Evidence-Based Medicine | 5 | 2014 | 3611 | 0.160 |
Why?
|
Professional Misconduct | 2 | 2004 | 73 | 0.160 |
Why?
|
Economics, Hospital | 2 | 2007 | 213 | 0.160 |
Why?
|
Preventive Health Services | 2 | 2001 | 575 | 0.160 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2013 | 923 | 0.160 |
Why?
|
Policy Making | 5 | 2006 | 554 | 0.160 |
Why?
|
Patient Care Planning | 1 | 2003 | 921 | 0.150 |
Why?
|
Ethics, Research | 1 | 1999 | 190 | 0.150 |
Why?
|
Patient Education as Topic | 5 | 2016 | 2275 | 0.150 |
Why?
|
Metformin | 3 | 2014 | 829 | 0.150 |
Why?
|
Pennsylvania | 6 | 2017 | 613 | 0.150 |
Why?
|
Uridine Monophosphate | 2 | 2015 | 69 | 0.150 |
Why?
|
Aged, 80 and over | 21 | 2019 | 57683 | 0.150 |
Why?
|
Matched-Pair Analysis | 2 | 2013 | 288 | 0.150 |
Why?
|
Financial Management, Hospital | 3 | 2005 | 74 | 0.150 |
Why?
|
Health Personnel | 3 | 2013 | 3210 | 0.150 |
Why?
|
Cohort Studies | 18 | 2021 | 40450 | 0.150 |
Why?
|
Reproductive Behavior | 1 | 1996 | 29 | 0.140 |
Why?
|
beta-Alanine | 2 | 2014 | 74 | 0.140 |
Why?
|
Patient Readmission | 4 | 2016 | 3111 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2003 | 956 | 0.140 |
Why?
|
Home Infusion Therapy | 1 | 2016 | 19 | 0.140 |
Why?
|
Ambulances | 1 | 1997 | 95 | 0.140 |
Why?
|
Sulfonylurea Compounds | 3 | 2014 | 204 | 0.140 |
Why?
|
Medical Indigency | 2 | 1993 | 64 | 0.140 |
Why?
|
Philosophy | 1 | 1996 | 66 | 0.140 |
Why?
|
Infant | 18 | 2014 | 35070 | 0.140 |
Why?
|
Ethical Analysis | 2 | 1993 | 42 | 0.140 |
Why?
|
Attitude of Health Personnel | 7 | 2011 | 3839 | 0.140 |
Why?
|
Age Factors | 13 | 2015 | 18355 | 0.140 |
Why?
|
Sexual Behavior | 2 | 1996 | 2050 | 0.140 |
Why?
|
Transportation of Patients | 1 | 1997 | 185 | 0.140 |
Why?
|
Community Pharmacy Services | 1 | 2016 | 46 | 0.130 |
Why?
|
Delivery, Obstetric | 1 | 2003 | 904 | 0.130 |
Why?
|
Odds Ratio | 12 | 2017 | 9846 | 0.130 |
Why?
|
Patient Participation | 3 | 2020 | 1445 | 0.130 |
Why?
|
Morbidity | 4 | 2013 | 1767 | 0.130 |
Why?
|
Formularies as Topic | 1 | 2016 | 91 | 0.130 |
Why?
|
Pharmacy Service, Hospital | 1 | 2016 | 133 | 0.130 |
Why?
|
Diagnosis-Related Groups | 3 | 2003 | 454 | 0.130 |
Why?
|
Polypharmacy | 3 | 2015 | 294 | 0.130 |
Why?
|
Personal Satisfaction | 1 | 2000 | 634 | 0.130 |
Why?
|
Emergencies | 2 | 1998 | 1164 | 0.130 |
Why?
|
Clinical Protocols | 2 | 1991 | 1459 | 0.130 |
Why?
|
Florida | 3 | 2005 | 435 | 0.130 |
Why?
|
Public Relations | 1 | 1994 | 22 | 0.130 |
Why?
|
Decision Making, Computer-Assisted | 2 | 1998 | 150 | 0.130 |
Why?
|
Health Care Rationing | 5 | 2004 | 435 | 0.130 |
Why?
|
Marriage | 1 | 1996 | 338 | 0.130 |
Why?
|
Ethics Committees, Research | 4 | 2003 | 194 | 0.130 |
Why?
|
Cystitis | 1 | 1995 | 92 | 0.120 |
Why?
|
Communication Barriers | 3 | 2003 | 398 | 0.120 |
Why?
|
Benzimidazoles | 3 | 2015 | 848 | 0.120 |
Why?
|
Complementary Therapies | 1 | 1998 | 484 | 0.120 |
Why?
|
Resuscitation | 3 | 1988 | 657 | 0.120 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2014 | 112 | 0.120 |
Why?
|
Professional Staff Committees | 3 | 1988 | 38 | 0.120 |
Why?
|
Palliative Care | 1 | 2009 | 3478 | 0.120 |
Why?
|
National Health Insurance, United States | 1 | 1994 | 104 | 0.120 |
Why?
|
Child, Preschool | 16 | 2014 | 40955 | 0.120 |
Why?
|
Medical Futility | 2 | 1993 | 126 | 0.120 |
Why?
|
Family | 6 | 2003 | 3144 | 0.120 |
Why?
|
Economics, Medical | 4 | 2007 | 113 | 0.120 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1995 | 708 | 0.120 |
Why?
|
Informed Consent | 5 | 2003 | 991 | 0.120 |
Why?
|
Prescriptions | 1 | 2016 | 387 | 0.120 |
Why?
|
Electronic Mail | 1 | 2016 | 213 | 0.120 |
Why?
|
Oseltamivir | 1 | 2014 | 75 | 0.120 |
Why?
|
Expert Testimony | 3 | 1996 | 356 | 0.120 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2016 | 648 | 0.120 |
Why?
|
Morpholines | 2 | 2014 | 561 | 0.120 |
Why?
|
Capital Punishment | 1 | 1993 | 31 | 0.120 |
Why?
|
Death | 1 | 1998 | 675 | 0.110 |
Why?
|
Inpatients | 4 | 2021 | 2495 | 0.110 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1995 | 370 | 0.110 |
Why?
|
Professional Practice | 3 | 2007 | 326 | 0.110 |
Why?
|
Judicial Role | 3 | 2006 | 37 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2001 | 2763 | 0.110 |
Why?
|
Ethical Theory | 3 | 1999 | 33 | 0.110 |
Why?
|
Secondary Prevention | 3 | 2015 | 1520 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2014 | 1239 | 0.110 |
Why?
|
Economic Competition | 1 | 2015 | 214 | 0.110 |
Why?
|
Pharyngitis | 1 | 2014 | 215 | 0.110 |
Why?
|
Dyslipidemias | 2 | 2018 | 848 | 0.110 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2015 | 1208 | 0.110 |
Why?
|
Ethics, Clinical | 1 | 1993 | 99 | 0.110 |
Why?
|
Education, Medical, Continuing | 3 | 2009 | 839 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2014 | 11695 | 0.110 |
Why?
|
Data Mining | 1 | 2017 | 537 | 0.110 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2012 | 44 | 0.110 |
Why?
|
Workers' Compensation | 3 | 1988 | 152 | 0.110 |
Why?
|
Retirement | 1 | 1994 | 215 | 0.110 |
Why?
|
Writing | 1 | 1994 | 205 | 0.110 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2013 | 257 | 0.110 |
Why?
|
Drug and Narcotic Control | 1 | 2013 | 146 | 0.110 |
Why?
|
Financing, Personal | 2 | 2014 | 308 | 0.100 |
Why?
|
Pyridones | 2 | 2014 | 712 | 0.100 |
Why?
|
Otitis Media | 1 | 2014 | 277 | 0.100 |
Why?
|
Information Systems | 1 | 1994 | 410 | 0.100 |
Why?
|
Models, Econometric | 2 | 2011 | 219 | 0.100 |
Why?
|
Drug Substitution | 2 | 2013 | 281 | 0.100 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2009 | 430 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2005 | 20774 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15530 | 0.100 |
Why?
|
Case-Control Studies | 9 | 2021 | 21719 | 0.100 |
Why?
|
Utilization Review | 3 | 1999 | 392 | 0.100 |
Why?
|
Hormones | 1 | 2016 | 884 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2004 | 3527 | 0.100 |
Why?
|
Prospective Studies | 15 | 2015 | 53187 | 0.100 |
Why?
|
Paternalism | 2 | 1988 | 45 | 0.100 |
Why?
|
Connecticut | 3 | 2009 | 363 | 0.100 |
Why?
|
Australia | 3 | 2000 | 1167 | 0.100 |
Why?
|
Hospital Information Systems | 3 | 1999 | 395 | 0.100 |
Why?
|
Sick Leave | 1 | 2012 | 110 | 0.100 |
Why?
|
Kidney Transplantation | 1 | 2007 | 4246 | 0.100 |
Why?
|
Nonprescription Drugs | 1 | 2012 | 116 | 0.100 |
Why?
|
Medication Errors | 4 | 2016 | 797 | 0.100 |
Why?
|
United States Federal Trade Commission | 2 | 2012 | 10 | 0.100 |
Why?
|
Lipoproteins, LDL | 1 | 2014 | 628 | 0.100 |
Why?
|
Occupational Diseases | 3 | 1991 | 1472 | 0.100 |
Why?
|
Human Genome Project | 1 | 1992 | 192 | 0.100 |
Why?
|
Peripheral Vascular Diseases | 1 | 1994 | 550 | 0.100 |
Why?
|
Consumer Product Safety | 2 | 2012 | 122 | 0.100 |
Why?
|
Incidence | 7 | 2021 | 20928 | 0.100 |
Why?
|
Credentialing | 2 | 2003 | 126 | 0.100 |
Why?
|
United States Agency for Healthcare Research and Quality | 2 | 2005 | 92 | 0.100 |
Why?
|
New Zealand | 4 | 2007 | 357 | 0.100 |
Why?
|
Models, Statistical | 6 | 2017 | 5100 | 0.100 |
Why?
|
Azetidines | 1 | 2012 | 142 | 0.100 |
Why?
|
History, 21st Century | 2 | 2009 | 1533 | 0.100 |
Why?
|
Absenteeism | 1 | 2012 | 250 | 0.090 |
Why?
|
Medicine | 5 | 2008 | 941 | 0.090 |
Why?
|
Radiology, Interventional | 1 | 1994 | 460 | 0.090 |
Why?
|
Obesity | 3 | 2013 | 12705 | 0.090 |
Why?
|
Antidepressive Agents | 3 | 2017 | 2838 | 0.090 |
Why?
|
Cause of Death | 2 | 2001 | 3571 | 0.090 |
Why?
|
Child | 19 | 2014 | 77478 | 0.090 |
Why?
|
Interviews as Topic | 4 | 2005 | 2536 | 0.090 |
Why?
|
Critical Care | 1 | 2003 | 2640 | 0.090 |
Why?
|
Critical Illness | 1 | 2003 | 2665 | 0.090 |
Why?
|
Anti-Obesity Agents | 1 | 2013 | 215 | 0.090 |
Why?
|
Organizational Objectives | 2 | 2005 | 438 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2016 | 503 | 0.090 |
Why?
|
Medicare Part D | 2 | 2015 | 326 | 0.090 |
Why?
|
Beneficence | 4 | 1993 | 53 | 0.090 |
Why?
|
Angioplasty, Balloon | 1 | 1994 | 653 | 0.090 |
Why?
|
Hazardous Waste | 1 | 1990 | 24 | 0.090 |
Why?
|
AIDS Serodiagnosis | 1 | 1991 | 184 | 0.090 |
Why?
|
Nurse Practitioners | 1 | 2013 | 270 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2015 | 1073 | 0.090 |
Why?
|
Urinary Fistula | 1 | 1990 | 41 | 0.090 |
Why?
|
Research Support as Topic | 1 | 1994 | 704 | 0.090 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2014 | 457 | 0.090 |
Why?
|
Cesarean Section | 2 | 2016 | 1363 | 0.090 |
Why?
|
Ureteral Diseases | 1 | 1990 | 61 | 0.090 |
Why?
|
Telephone | 2 | 2010 | 617 | 0.090 |
Why?
|
Home Care Services | 1 | 2016 | 602 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2013 | 3067 | 0.090 |
Why?
|
Personnel, Hospital | 2 | 1991 | 283 | 0.090 |
Why?
|
Mortality | 1 | 2001 | 2857 | 0.090 |
Why?
|
Phentermine | 2 | 2013 | 33 | 0.090 |
Why?
|
Career Choice | 2 | 2005 | 743 | 0.090 |
Why?
|
Influenza, Human | 2 | 2014 | 1472 | 0.080 |
Why?
|
Diabetes Mellitus | 3 | 2014 | 5724 | 0.080 |
Why?
|
Anesthesiology | 1 | 1999 | 1043 | 0.080 |
Why?
|
Intestinal Fistula | 1 | 1990 | 140 | 0.080 |
Why?
|
Hazardous Substances | 1 | 1990 | 149 | 0.080 |
Why?
|
Nursing Care | 1 | 2009 | 74 | 0.080 |
Why?
|
Europe | 1 | 2015 | 3339 | 0.080 |
Why?
|
Sex Factors | 5 | 2015 | 10392 | 0.080 |
Why?
|
Institutional Management Teams | 2 | 2000 | 31 | 0.080 |
Why?
|
Euthanasia | 1 | 1988 | 51 | 0.080 |
Why?
|
Anticoagulants | 2 | 2014 | 4595 | 0.080 |
Why?
|
Risk Factors | 19 | 2016 | 72145 | 0.080 |
Why?
|
Legislation, Hospital | 1 | 1988 | 12 | 0.080 |
Why?
|
Warfarin | 2 | 2014 | 1493 | 0.080 |
Why?
|
Publication Bias | 1 | 2009 | 161 | 0.080 |
Why?
|
Urinary Tract Infections | 1 | 2014 | 786 | 0.080 |
Why?
|
Insulin | 1 | 2023 | 6575 | 0.080 |
Why?
|
Sweden | 3 | 2007 | 1343 | 0.080 |
Why?
|
Intraoperative Complications | 2 | 1999 | 1188 | 0.080 |
Why?
|
Pandemics | 2 | 2021 | 8328 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 886 | 0.080 |
Why?
|
Colonic Diseases | 1 | 1990 | 202 | 0.080 |
Why?
|
Social Support | 1 | 2018 | 2117 | 0.080 |
Why?
|
Federal Government | 2 | 1999 | 260 | 0.080 |
Why?
|
Ticlopidine | 1 | 2013 | 899 | 0.080 |
Why?
|
Budgets | 2 | 1999 | 227 | 0.080 |
Why?
|
Sampling Studies | 5 | 1996 | 623 | 0.080 |
Why?
|
Biomedical Research | 1 | 2003 | 3306 | 0.080 |
Why?
|
Policy | 2 | 2022 | 504 | 0.080 |
Why?
|
Organizational Case Studies | 1 | 2008 | 299 | 0.080 |
Why?
|
Judgment | 1 | 1989 | 281 | 0.080 |
Why?
|
United States Government Agencies | 1 | 2007 | 26 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2015 | 19862 | 0.070 |
Why?
|
Long-Term Care | 1 | 2011 | 607 | 0.070 |
Why?
|
Hospitals, University | 3 | 1995 | 571 | 0.070 |
Why?
|
Management Quality Circles | 2 | 2000 | 21 | 0.070 |
Why?
|
Chi-Square Distribution | 3 | 2000 | 3510 | 0.070 |
Why?
|
Poverty | 3 | 2000 | 2646 | 0.070 |
Why?
|
Research Design | 3 | 2015 | 5979 | 0.070 |
Why?
|
Publishing | 1 | 1994 | 833 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1847 | 0.070 |
Why?
|
Risk Adjustment | 2 | 2000 | 594 | 0.070 |
Why?
|
Researcher-Subject Relations | 2 | 1999 | 16 | 0.070 |
Why?
|
Young Adult | 12 | 2017 | 56350 | 0.070 |
Why?
|
Pyrazoles | 2 | 2014 | 1970 | 0.070 |
Why?
|
Societies, Medical | 4 | 2004 | 3740 | 0.070 |
Why?
|
Employee Discipline | 1 | 2006 | 8 | 0.070 |
Why?
|
Time Factors | 10 | 2020 | 40054 | 0.070 |
Why?
|
Administration, Oral | 5 | 2014 | 3913 | 0.070 |
Why?
|
Disabled Persons | 5 | 2000 | 1209 | 0.070 |
Why?
|
Ethics, Institutional | 1 | 2006 | 37 | 0.070 |
Why?
|
Smoking Cessation | 2 | 2015 | 2068 | 0.070 |
Why?
|
Self-Evaluation Programs | 1 | 2005 | 29 | 0.070 |
Why?
|
Environmental Pollutants | 1 | 1995 | 1180 | 0.070 |
Why?
|
Developing Countries | 1 | 1998 | 2789 | 0.070 |
Why?
|
Viremia | 1 | 2009 | 735 | 0.070 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1638 | 0.070 |
Why?
|
Fees and Charges | 2 | 2004 | 195 | 0.070 |
Why?
|
HIV Infections | 7 | 2009 | 16678 | 0.070 |
Why?
|
Internet | 2 | 2016 | 3062 | 0.070 |
Why?
|
Ethics Committees | 3 | 1992 | 53 | 0.070 |
Why?
|
Forecasting | 3 | 2017 | 2948 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2015 | 1914 | 0.070 |
Why?
|
Hospital Restructuring | 1 | 2005 | 10 | 0.070 |
Why?
|
Hospital Shared Services | 1 | 2005 | 16 | 0.070 |
Why?
|
Biological Products | 1 | 2014 | 856 | 0.070 |
Why?
|
California | 3 | 2017 | 1400 | 0.070 |
Why?
|
Breast Self-Examination | 1 | 2005 | 34 | 0.060 |
Why?
|
Zidovudine | 2 | 1998 | 620 | 0.060 |
Why?
|
Deductibles and Coinsurance | 2 | 2011 | 316 | 0.060 |
Why?
|
Atrial Fibrillation | 2 | 2014 | 5019 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2014 | 13655 | 0.060 |
Why?
|
Perception | 1 | 1992 | 1188 | 0.060 |
Why?
|
Regression Analysis | 3 | 2017 | 6452 | 0.060 |
Why?
|
Computers | 2 | 1999 | 611 | 0.060 |
Why?
|
HIV Seropositivity | 2 | 1994 | 970 | 0.060 |
Why?
|
Pilot Projects | 5 | 2016 | 8297 | 0.060 |
Why?
|
Probability | 3 | 2003 | 2502 | 0.060 |
Why?
|
Research | 2 | 1997 | 1999 | 0.060 |
Why?
|
Disease Outbreaks | 2 | 2005 | 1768 | 0.060 |
Why?
|
New England | 2 | 1998 | 1021 | 0.060 |
Why?
|
Depressive Disorder | 1 | 2017 | 3748 | 0.060 |
Why?
|
Peer Review | 4 | 2001 | 208 | 0.060 |
Why?
|
Acute Disease | 3 | 2003 | 7141 | 0.060 |
Why?
|
Coronary Artery Bypass | 1 | 2013 | 2281 | 0.060 |
Why?
|
Hospital Bed Capacity, 500 and over | 3 | 1998 | 115 | 0.060 |
Why?
|
Antihypertensive Agents | 4 | 2017 | 2043 | 0.060 |
Why?
|
Age Distribution | 3 | 2005 | 2900 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2017 | 4440 | 0.060 |
Why?
|
Dexfenfluramine | 1 | 2003 | 8 | 0.060 |
Why?
|
Risk | 5 | 1999 | 9679 | 0.060 |
Why?
|
Food Labeling | 1 | 2006 | 178 | 0.060 |
Why?
|
Retreatment | 2 | 2011 | 604 | 0.060 |
Why?
|
Concurrent Review | 1 | 2002 | 13 | 0.060 |
Why?
|
Television | 1 | 2006 | 409 | 0.060 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2003 | 90 | 0.060 |
Why?
|
Health Care Coalitions | 1 | 2003 | 35 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2003 | 6365 | 0.060 |
Why?
|
Models, Organizational | 1 | 2007 | 574 | 0.060 |
Why?
|
Occupational Medicine | 1 | 1983 | 110 | 0.060 |
Why?
|
Fenfluramine | 1 | 2003 | 60 | 0.060 |
Why?
|
Health Behavior | 2 | 2007 | 2630 | 0.060 |
Why?
|
Hospitals, Maternity | 1 | 2003 | 42 | 0.060 |
Why?
|
Risk Assessment | 8 | 2017 | 23320 | 0.060 |
Why?
|
Piperazines | 1 | 2013 | 2488 | 0.060 |
Why?
|
Surgical Sponges | 1 | 2003 | 46 | 0.060 |
Why?
|
Program Development | 1 | 2009 | 1314 | 0.050 |
Why?
|
Chromans | 1 | 2003 | 122 | 0.050 |
Why?
|
Trust | 3 | 1997 | 501 | 0.050 |
Why?
|
Rhode Island | 2 | 2016 | 347 | 0.050 |
Why?
|
Statistics as Topic | 4 | 2015 | 2372 | 0.050 |
Why?
|
Opioid-Related Disorders | 1 | 2017 | 2062 | 0.050 |
Why?
|
Drug Therapy, Combination | 4 | 2015 | 6483 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 1998 | 7901 | 0.050 |
Why?
|
Confidence Intervals | 4 | 2002 | 2970 | 0.050 |
Why?
|
Pediatric Nursing | 1 | 2003 | 103 | 0.050 |
Why?
|
Technology, High-Cost | 1 | 2002 | 32 | 0.050 |
Why?
|
Michigan | 1 | 2003 | 350 | 0.050 |
Why?
|
Weight Loss | 1 | 2013 | 2604 | 0.050 |
Why?
|
Group Processes | 2 | 2015 | 225 | 0.050 |
Why?
|
Public Opinion | 1 | 2006 | 477 | 0.050 |
Why?
|
Labor Unions | 1 | 2001 | 47 | 0.050 |
Why?
|
Chest Pain | 2 | 1999 | 1113 | 0.050 |
Why?
|
Professional Practice Location | 2 | 2005 | 59 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2015 | 14720 | 0.050 |
Why?
|
West Nile Fever | 1 | 2001 | 78 | 0.050 |
Why?
|
Hospital Mortality | 3 | 2010 | 5310 | 0.050 |
Why?
|
Actuarial Analysis | 1 | 2001 | 377 | 0.050 |
Why?
|
Dyspnea | 2 | 1999 | 1298 | 0.050 |
Why?
|
DNA | 1 | 1995 | 7289 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2003 | 317 | 0.050 |
Why?
|
Smoking | 2 | 2016 | 8969 | 0.050 |
Why?
|
Family Relations | 1 | 2003 | 321 | 0.050 |
Why?
|
Government | 1 | 2022 | 165 | 0.050 |
Why?
|
Random Allocation | 4 | 1995 | 2425 | 0.050 |
Why?
|
Clinical Competence | 4 | 2005 | 4681 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2003 | 15056 | 0.050 |
Why?
|
Gatekeeping | 1 | 2000 | 45 | 0.050 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2009 | 1872 | 0.050 |
Why?
|
Markov Chains | 2 | 2015 | 969 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2012 | 4567 | 0.050 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2337 | 0.050 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 1998 | 1320 | 0.040 |
Why?
|
Patient Transfer | 2 | 2016 | 760 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2003 | 394 | 0.040 |
Why?
|
Epilepsy | 1 | 2015 | 3301 | 0.040 |
Why?
|
Terminal Care | 2 | 1988 | 1688 | 0.040 |
Why?
|
Pregnancy | 8 | 2016 | 29087 | 0.040 |
Why?
|
Empirical Research | 1 | 2000 | 120 | 0.040 |
Why?
|
Sentinel Surveillance | 2 | 2000 | 281 | 0.040 |
Why?
|
Contract Services | 1 | 1999 | 94 | 0.040 |
Why?
|
Caregivers | 1 | 2011 | 2074 | 0.040 |
Why?
|
Models, Economic | 2 | 2015 | 713 | 0.040 |
Why?
|
Epidemiologic Methods | 4 | 1992 | 1364 | 0.040 |
Why?
|
Uterine Hemorrhage | 2 | 1999 | 255 | 0.040 |
Why?
|
Gynecology | 1 | 2005 | 509 | 0.040 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 1999 | 99 | 0.040 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2014 | 292 | 0.040 |
Why?
|
Psychiatric Nursing | 1 | 1998 | 17 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 264 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2002 | 20086 | 0.040 |
Why?
|
Neurosurgery | 1 | 2005 | 642 | 0.040 |
Why?
|
Epidemiologic Research Design | 1 | 2002 | 367 | 0.040 |
Why?
|
Educational Measurement | 1 | 2005 | 1206 | 0.040 |
Why?
|
Foreign Bodies | 1 | 2003 | 398 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2000 | 207 | 0.040 |
Why?
|
Motivation | 2 | 2020 | 1968 | 0.040 |
Why?
|
Occupational Exposure | 2 | 1991 | 1794 | 0.040 |
Why?
|
Professional-Patient Relations | 2 | 2016 | 736 | 0.040 |
Why?
|
Telemedicine | 1 | 2015 | 2853 | 0.040 |
Why?
|
Investments | 1 | 1999 | 143 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12344 | 0.040 |
Why?
|
Universities | 1 | 2003 | 953 | 0.040 |
Why?
|
Cost of Illness | 3 | 2010 | 1852 | 0.040 |
Why?
|
Licensure | 1 | 1998 | 124 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2885 | 0.040 |
Why?
|
Contracts | 1 | 1998 | 60 | 0.040 |
Why?
|
Injury Severity Score | 2 | 2007 | 1013 | 0.040 |
Why?
|
Financial Management | 1 | 1999 | 160 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 1990 | 2542 | 0.040 |
Why?
|
Coercion | 1 | 1998 | 63 | 0.040 |
Why?
|
Postoperative Complications | 3 | 2013 | 15244 | 0.040 |
Why?
|
Insurance Selection Bias | 1 | 1998 | 67 | 0.040 |
Why?
|
Efficiency | 1 | 2001 | 462 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2000 | 392 | 0.040 |
Why?
|
Accident Prevention | 2 | 1994 | 78 | 0.040 |
Why?
|
Infant Welfare | 1 | 1997 | 82 | 0.040 |
Why?
|
APACHE | 1 | 1998 | 277 | 0.040 |
Why?
|
Professional Autonomy | 2 | 2004 | 177 | 0.040 |
Why?
|
Blood Banks | 1 | 1998 | 110 | 0.040 |
Why?
|
Licensure, Medical | 1 | 1998 | 62 | 0.040 |
Why?
|
Greek World | 1 | 1996 | 6 | 0.040 |
Why?
|
Illinois | 1 | 2017 | 119 | 0.040 |
Why?
|
Data Display | 1 | 1997 | 182 | 0.040 |
Why?
|
Algorithms | 1 | 2017 | 13853 | 0.040 |
Why?
|
Maternal Welfare | 1 | 1997 | 115 | 0.040 |
Why?
|
Morals | 2 | 1996 | 282 | 0.040 |
Why?
|
Hand Injuries | 1 | 1999 | 242 | 0.040 |
Why?
|
Ancillary Services, Hospital | 1 | 1996 | 23 | 0.040 |
Why?
|
Quality-Adjusted Life Years | 2 | 2013 | 1679 | 0.040 |
Why?
|
Needs Assessment | 1 | 2002 | 1146 | 0.040 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2000 | 469 | 0.040 |
Why?
|
Child Rearing | 1 | 1996 | 74 | 0.030 |
Why?
|
History, Ancient | 1 | 1996 | 212 | 0.030 |
Why?
|
Feedback | 1 | 2000 | 793 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2003 | 830 | 0.030 |
Why?
|
Databases, Factual | 3 | 2016 | 7716 | 0.030 |
Why?
|
Orthopedics | 1 | 2005 | 903 | 0.030 |
Why?
|
Income | 4 | 2014 | 1904 | 0.030 |
Why?
|
Phosphoric Acids | 1 | 1995 | 24 | 0.030 |
Why?
|
Torture | 2 | 1994 | 53 | 0.030 |
Why?
|
Software Design | 1 | 1996 | 176 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2005 | 1205 | 0.030 |
Why?
|
Fear | 1 | 2004 | 1436 | 0.030 |
Why?
|
Hospital Charges | 1 | 1997 | 362 | 0.030 |
Why?
|
Thiazoles | 1 | 2003 | 1484 | 0.030 |
Why?
|
Pregnancy Complications, Infectious | 2 | 1998 | 2026 | 0.030 |
Why?
|
Postnatal Care | 1 | 1997 | 235 | 0.030 |
Why?
|
Health Facility Merger | 1 | 1996 | 53 | 0.030 |
Why?
|
Regional Health Planning | 1 | 2015 | 97 | 0.030 |
Why?
|
Craniocerebral Trauma | 1 | 1999 | 482 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 1999 | 431 | 0.030 |
Why?
|
Respiratory System Agents | 1 | 2014 | 29 | 0.030 |
Why?
|
Advance Directives | 1 | 1997 | 245 | 0.030 |
Why?
|
Depression, Postpartum | 1 | 1999 | 339 | 0.030 |
Why?
|
Indicators and Reagents | 1 | 1995 | 462 | 0.030 |
Why?
|
Nutrition Disorders | 1 | 1995 | 211 | 0.030 |
Why?
|
Pensions | 1 | 1994 | 15 | 0.030 |
Why?
|
Editorial Policies | 1 | 1999 | 451 | 0.030 |
Why?
|
Pregnant Women | 1 | 1999 | 566 | 0.030 |
Why?
|
Fees, Pharmaceutical | 1 | 2014 | 64 | 0.030 |
Why?
|
Vagina | 1 | 1999 | 825 | 0.030 |
Why?
|
Homicide | 1 | 1997 | 287 | 0.030 |
Why?
|
Biometry | 1 | 1997 | 558 | 0.030 |
Why?
|
Preferred Provider Organizations | 1 | 1994 | 38 | 0.030 |
Why?
|
Placebos | 1 | 1998 | 1677 | 0.030 |
Why?
|
Neoplasms | 3 | 2014 | 21596 | 0.030 |
Why?
|
Education, Medical | 1 | 2006 | 1717 | 0.030 |
Why?
|
Medical Record Linkage | 1 | 2015 | 284 | 0.030 |
Why?
|
Casuistry | 1 | 1993 | 2 | 0.030 |
Why?
|
Fluorenes | 1 | 2015 | 159 | 0.030 |
Why?
|
Biotransformation | 1 | 2013 | 168 | 0.030 |
Why?
|
General Surgery | 1 | 2005 | 1633 | 0.030 |
Why?
|
Cyclobutanes | 1 | 2013 | 59 | 0.030 |
Why?
|
Carbamates | 1 | 2015 | 195 | 0.030 |
Why?
|
Child Health Services | 1 | 1999 | 667 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 1999 | 740 | 0.030 |
Why?
|
Primary Prevention | 1 | 2001 | 1166 | 0.030 |
Why?
|
Professional Role | 1 | 2016 | 306 | 0.030 |
Why?
|
Valine | 1 | 2015 | 413 | 0.030 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2015 | 215 | 0.030 |
Why?
|
Cultural Diversity | 1 | 1997 | 358 | 0.030 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 1993 | 43 | 0.030 |
Why?
|
Ribavirin | 1 | 2015 | 395 | 0.030 |
Why?
|
Environmental Exposure | 1 | 1987 | 4231 | 0.030 |
Why?
|
Lead Poisoning | 1 | 1995 | 304 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 2014 | 245 | 0.030 |
Why?
|
Pyrrolidines | 1 | 2015 | 342 | 0.030 |
Why?
|
Ethical Relativism | 1 | 1992 | 6 | 0.030 |
Why?
|
Automation | 1 | 1995 | 584 | 0.030 |
Why?
|
Gulf War | 1 | 1992 | 29 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2000 | 1503 | 0.030 |
Why?
|
Amides | 1 | 1995 | 458 | 0.030 |
Why?
|
Sex | 1 | 2012 | 57 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 600 | 0.030 |
Why?
|
Quality Control | 2 | 2011 | 841 | 0.030 |
Why?
|
Iraq | 1 | 1992 | 92 | 0.030 |
Why?
|
Kuwait | 1 | 1992 | 86 | 0.030 |
Why?
|
Substance-Related Disorders | 2 | 2016 | 4250 | 0.030 |
Why?
|
Accidents | 1 | 1993 | 164 | 0.030 |
Why?
|
alpha-Glucosidases | 1 | 2012 | 44 | 0.030 |
Why?
|
Ethical Review | 1 | 1992 | 26 | 0.030 |
Why?
|
Outpatients | 1 | 2000 | 1483 | 0.030 |
Why?
|
Right to Die | 1 | 1992 | 32 | 0.030 |
Why?
|
Demography | 1 | 1997 | 1650 | 0.030 |
Why?
|
Abdominal Pain | 1 | 1998 | 1059 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 1996 | 414 | 0.030 |
Why?
|
Bioethical Issues | 1 | 1993 | 124 | 0.030 |
Why?
|
Accidental Falls | 1 | 2000 | 1057 | 0.030 |
Why?
|
Bioethics | 1 | 1993 | 115 | 0.030 |
Why?
|
Vitamin K | 1 | 2014 | 294 | 0.030 |
Why?
|
Back Pain | 1 | 2016 | 545 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 1997 | 783 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1995 | 1574 | 0.020 |
Why?
|
Health Status Indicators | 1 | 1997 | 968 | 0.020 |
Why?
|
HIV-1 | 1 | 2009 | 6934 | 0.020 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 1991 | 28 | 0.020 |
Why?
|
Operating Rooms | 1 | 1998 | 813 | 0.020 |
Why?
|
Lactones | 1 | 2013 | 329 | 0.020 |
Why?
|
Patient Rights | 1 | 1992 | 125 | 0.020 |
Why?
|
Radiology | 1 | 2005 | 2090 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39004 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2714 | 0.020 |
Why?
|
Health | 1 | 1994 | 390 | 0.020 |
Why?
|
Interferon-alpha | 1 | 2015 | 895 | 0.020 |
Why?
|
Electronic Prescribing | 1 | 2011 | 121 | 0.020 |
Why?
|
Diethylstilbestrol | 2 | 1988 | 89 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2018 | 1423 | 0.020 |
Why?
|
Medical Record Administrators | 1 | 1989 | 3 | 0.020 |
Why?
|
Self Medication | 1 | 2011 | 117 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2012 | 9941 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2016 | 1101 | 0.020 |
Why?
|
Vaginal Neoplasms | 2 | 1988 | 106 | 0.020 |
Why?
|
Biotechnology | 1 | 1992 | 278 | 0.020 |
Why?
|
Hospitals, Rural | 1 | 1991 | 172 | 0.020 |
Why?
|
Genotype | 2 | 2015 | 12946 | 0.020 |
Why?
|
Contact Tracing | 1 | 1992 | 272 | 0.020 |
Why?
|
Accidents, Occupational | 1 | 1991 | 251 | 0.020 |
Why?
|
Language | 1 | 1999 | 1458 | 0.020 |
Why?
|
Privacy | 1 | 1992 | 237 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 681 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2013 | 676 | 0.020 |
Why?
|
Myocardial Revascularization | 1 | 2013 | 841 | 0.020 |
Why?
|
Carcinogenicity Tests | 1 | 1989 | 41 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2001 | 8621 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1526 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1158 | 0.020 |
Why?
|
Anti-HIV Agents | 2 | 2009 | 4250 | 0.020 |
Why?
|
Medical Informatics Applications | 1 | 2010 | 186 | 0.020 |
Why?
|
Hospital Costs | 1 | 1995 | 980 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1205 | 0.020 |
Why?
|
Mothers | 1 | 1999 | 2163 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 1998 | 1538 | 0.020 |
Why?
|
Directive Counseling | 1 | 2010 | 166 | 0.020 |
Why?
|
Cell Membrane | 1 | 1998 | 3744 | 0.020 |
Why?
|
Ethics, Professional | 1 | 1988 | 102 | 0.020 |
Why?
|
Financing, Government | 1 | 1992 | 468 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 1998 | 2575 | 0.020 |
Why?
|
Hemorrhage | 1 | 1999 | 3461 | 0.020 |
Why?
|
Hepacivirus | 1 | 2015 | 1372 | 0.020 |
Why?
|
Vulnerable Populations | 1 | 1993 | 685 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 1998 | 5519 | 0.020 |
Why?
|
Health Priorities | 1 | 2010 | 379 | 0.020 |
Why?
|
Reoperation | 2 | 2003 | 4200 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2010 | 559 | 0.020 |
Why?
|
Carcinogens | 1 | 1989 | 466 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4929 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2017 | 13921 | 0.020 |
Why?
|
Life Style | 1 | 1998 | 3824 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 1998 | 1914 | 0.020 |
Why?
|
Violence | 1 | 1992 | 908 | 0.020 |
Why?
|
Training Support | 1 | 2006 | 113 | 0.020 |
Why?
|
Cardiology | 1 | 1997 | 1658 | 0.020 |
Why?
|
Family Health | 1 | 2011 | 1282 | 0.020 |
Why?
|
Personnel Turnover | 1 | 2005 | 83 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5948 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1932 | 0.020 |
Why?
|
Mutagenicity Tests | 1 | 1985 | 46 | 0.020 |
Why?
|
Cytomegalovirus | 1 | 1990 | 730 | 0.020 |
Why?
|
Denmark | 1 | 2007 | 736 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 1548 | 0.020 |
Why?
|
History, 19th Century | 1 | 1987 | 720 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1990 | 1538 | 0.020 |
Why?
|
Sexual Partners | 1 | 1989 | 730 | 0.020 |
Why?
|
Philosophy, Medical | 1 | 1985 | 79 | 0.020 |
Why?
|
Quality of Life | 2 | 1998 | 12730 | 0.020 |
Why?
|
Value of Life | 1 | 1985 | 97 | 0.020 |
Why?
|
Hepatitis, Alcoholic | 1 | 1986 | 103 | 0.010 |
Why?
|
Professional Competence | 1 | 2007 | 448 | 0.010 |
Why?
|
Hospital-Physician Relations | 1 | 2003 | 18 | 0.010 |
Why?
|
Heart Diseases | 1 | 1997 | 2789 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2016 | 1620 | 0.010 |
Why?
|
Population Dynamics | 1 | 2005 | 301 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3058 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2013 | 2049 | 0.010 |
Why?
|
Attitude | 1 | 1988 | 772 | 0.010 |
Why?
|
Disability Evaluation | 1 | 1991 | 1827 | 0.010 |
Why?
|
Career Mobility | 1 | 2005 | 262 | 0.010 |
Why?
|
Hypertension | 2 | 2014 | 8455 | 0.010 |
Why?
|
Brain Injuries | 1 | 1995 | 2024 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 1992 | 2276 | 0.010 |
Why?
|
Information Dissemination | 1 | 2011 | 1100 | 0.010 |
Why?
|
Alleles | 1 | 2013 | 6931 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8333 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1849 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2007 | 1254 | 0.010 |
Why?
|
Biological Assay | 1 | 1985 | 652 | 0.010 |
Why?
|
Culicidae | 1 | 2001 | 104 | 0.010 |
Why?
|
West Nile virus | 1 | 2001 | 79 | 0.010 |
Why?
|
Insect Bites and Stings | 1 | 2001 | 67 | 0.010 |
Why?
|
Health Planning | 1 | 2002 | 237 | 0.010 |
Why?
|
Virus Replication | 1 | 2009 | 2531 | 0.010 |
Why?
|
Prognosis | 3 | 1992 | 29010 | 0.010 |
Why?
|
Genetic Testing | 1 | 2013 | 3439 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2015 | 4030 | 0.010 |
Why?
|
Germany | 1 | 2002 | 860 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1998 | 10163 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 2001 | 402 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 62966 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2012 | 3656 | 0.010 |
Why?
|
Stroke Volume | 1 | 2012 | 4983 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2003 | 517 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 1990 | 3164 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13256 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1985 | 1780 | 0.010 |
Why?
|
Vaginal Smears | 1 | 2001 | 511 | 0.010 |
Why?
|
New Jersey | 1 | 1998 | 290 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 3038 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 1998 | 402 | 0.010 |
Why?
|
Sex Distribution | 1 | 2002 | 2295 | 0.010 |
Why?
|
Computer Communication Networks | 1 | 1999 | 295 | 0.010 |
Why?
|
Jurkat Cells | 1 | 1998 | 742 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2593 | 0.010 |
Why?
|
Laboratories, Hospital | 1 | 1997 | 194 | 0.010 |
Why?
|
Computer Systems | 1 | 1997 | 483 | 0.010 |
Why?
|
Systems Integration | 1 | 1998 | 440 | 0.010 |
Why?
|
Models, Theoretical | 1 | 1988 | 3584 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1988 | 2011 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 1988 | 2407 | 0.010 |
Why?
|
Cultural Characteristics | 1 | 1997 | 262 | 0.010 |
Why?
|
Thailand | 1 | 1995 | 296 | 0.010 |
Why?
|
Signal Transduction | 1 | 1998 | 23387 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1995 | 187 | 0.010 |
Why?
|
Body Mass Index | 2 | 2003 | 12695 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 1999 | 694 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 1997 | 412 | 0.010 |
Why?
|
Asthma | 1 | 2012 | 5955 | 0.010 |
Why?
|
Religion | 1 | 1997 | 356 | 0.010 |
Why?
|
Psychometrics | 1 | 2002 | 2999 | 0.010 |
Why?
|
Dogs | 1 | 1998 | 3910 | 0.010 |
Why?
|
Positive-Pressure Respiration | 1 | 1977 | 632 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1988 | 6347 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1985 | 10943 | 0.010 |
Why?
|
Focus Groups | 1 | 1997 | 1320 | 0.010 |
Why?
|
Cholesterol | 1 | 2001 | 2895 | 0.010 |
Why?
|
Aging | 1 | 2011 | 8626 | 0.010 |
Why?
|
Social Class | 1 | 2001 | 1995 | 0.010 |
Why?
|
Stroke | 1 | 2014 | 9963 | 0.010 |
Why?
|
Personnel Selection | 1 | 1992 | 189 | 0.010 |
Why?
|
Decision Support Systems, Clinical | 1 | 1999 | 1162 | 0.010 |
Why?
|
Population Surveillance | 1 | 2000 | 2616 | 0.010 |
Why?
|
Wound Infection | 1 | 1991 | 240 | 0.010 |
Why?
|
Urban Population | 1 | 1997 | 2018 | 0.010 |
Why?
|
Heart Failure | 1 | 2012 | 10856 | 0.000 |
Why?
|
Space-Time Clustering | 1 | 1988 | 49 | 0.000 |
Why?
|
Comorbidity | 1 | 2002 | 10372 | 0.000 |
Why?
|
Qualitative Research | 1 | 1997 | 2680 | 0.000 |
Why?
|
International Cooperation | 1 | 1994 | 1421 | 0.000 |
Why?
|
Rheumatic Diseases | 1 | 1992 | 590 | 0.000 |
Why?
|
Cluster Analysis | 1 | 1993 | 2713 | 0.000 |
Why?
|
Mass Screening | 1 | 2001 | 5238 | 0.000 |
Why?
|
Women's Health | 1 | 1994 | 2034 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1999 | 12958 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1989 | 1274 | 0.000 |
Why?
|
Patient Care Team | 1 | 1994 | 2527 | 0.000 |
Why?
|
Progestins | 1 | 1985 | 303 | 0.000 |
Why?
|
Abortion, Spontaneous | 1 | 1988 | 542 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3862 | 0.000 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1985 | 316 | 0.000 |
Why?
|
Animals | 3 | 2001 | 168561 | 0.000 |
Why?
|
Estrogens | 1 | 1985 | 1562 | 0.000 |
Why?
|
Pneumonia, Aspiration | 1 | 1977 | 144 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 1988 | 2861 | 0.000 |
Why?
|
Registries | 1 | 1988 | 8077 | 0.000 |
Why?
|